Oppenheimer & Co’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-476
Closed -$156K 1476
2022
Q2
$156K Buy
476
+129
+37% +$42.3K ﹤0.01% 1301
2022
Q1
$152K Sell
347
-30
-8% -$13.1K ﹤0.01% 1390
2021
Q4
$165K Sell
377
-152
-29% -$66.5K ﹤0.01% 1412
2021
Q3
$294K Buy
+529
New +$294K 0.01% 1234